Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?

This scientific commentary refers to ‘Distinct brain pathologies associated with Alzheimer’s disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-β amyloidosis’ by Hirota et al. (https://doi.org/10.1093/braincomms/fcac286) and ‘Predictive blood biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Saura, Carlos A, Parra-Damas, Arnaldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Scientific Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169699/
https://www.ncbi.nlm.nih.gov/pubmed/37180989
http://dx.doi.org/10.1093/braincomms/fcad142
_version_ 1785039096822890496
author Saura, Carlos A
Parra-Damas, Arnaldo
author_facet Saura, Carlos A
Parra-Damas, Arnaldo
author_sort Saura, Carlos A
collection PubMed
description This scientific commentary refers to ‘Distinct brain pathologies associated with Alzheimer’s disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-β amyloidosis’ by Hirota et al. (https://doi.org/10.1093/braincomms/fcac286) and ‘Predictive blood biomarkers and brain changes associated with age-related cognitive decline’ by Saunders et al. (https://doi.org/10.1093/braincomms/fcad113).
format Online
Article
Text
id pubmed-10169699
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101696992023-05-11 Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease? Saura, Carlos A Parra-Damas, Arnaldo Brain Commun Scientific Commentary This scientific commentary refers to ‘Distinct brain pathologies associated with Alzheimer’s disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-β amyloidosis’ by Hirota et al. (https://doi.org/10.1093/braincomms/fcac286) and ‘Predictive blood biomarkers and brain changes associated with age-related cognitive decline’ by Saunders et al. (https://doi.org/10.1093/braincomms/fcad113). Oxford University Press 2023-04-27 /pmc/articles/PMC10169699/ /pubmed/37180989 http://dx.doi.org/10.1093/braincomms/fcad142 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Guarantors of Brain. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Scientific Commentary
Saura, Carlos A
Parra-Damas, Arnaldo
Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
title Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
title_full Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
title_fullStr Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
title_full_unstemmed Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
title_short Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease?
title_sort is phosphorylated tau a good biomarker of synapse pathology in alzheimer’s disease?
topic Scientific Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169699/
https://www.ncbi.nlm.nih.gov/pubmed/37180989
http://dx.doi.org/10.1093/braincomms/fcad142
work_keys_str_mv AT sauracarlosa isphosphorylatedtauagoodbiomarkerofsynapsepathologyinalzheimersdisease
AT parradamasarnaldo isphosphorylatedtauagoodbiomarkerofsynapsepathologyinalzheimersdisease

Ejemplares similares